已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Ultra-low dose computed tomography protocols using spectral shaping for lung cancer screening: Comparison with low-dose for volumetric LungRADS classification

医学 肺癌 计算机断层摄影术 核医学 肺癌筛查 断层摄影术 放射科 内科学
作者
Gianluca Milanese,Roberta Eufrasia Ledda,Federica Sabia,Margherita Ruggirello,Stefano Sestini,Mario Silva,Nicola Sverzellati,Alfonso Marchianò,Ugo Pastorino
出处
期刊:European Journal of Radiology [Elsevier BV]
卷期号:161: 110760-110760 被引量:11
标识
DOI:10.1016/j.ejrad.2023.110760
摘要

To compare Low-Dose Computed Tomography (LDCT) with four different Ultra-Low-Dose Computed Tomography (ULDCT) protocols for PN classification according to the Lung Reporting and Data System (LungRADS).Three hundred sixty-one participants of an ongoing lung cancer screening (LCS) underwent single-breath-hold double chest Computed Tomography (CT), including LDCT (120kVp, 25mAs; CTDIvol 1,62 mGy) and one ULDCT among: fully automated exposure control ("ULDCT1"); fixed tube-voltage and current according to patient size ("ULDCT2"); hybrid approach with fixed tube-voltage ("ULDCT3") and tube current automated exposure control ("ULDCT4"). Two radiologists (R1, R2) assessed LungRADS 2022 categories on LDCT, and then after 2 weeks on ULDCT using two different kernels (R1: Qr49ADMIRE 4; R2: Br49ADMIRE 3). Intra-subject agreement for LungRADS categories between LDCT and ULDCT was measured by the k-Cohen Index with Fleiss-Cohen weights.LDCT-dominant PNs were detected in ULDCT in 87 % of cases on Qr49ADMIRE 4 and 88 % on Br49ADMIRE 3. The intra-subject agreement was: κULDCT1 = 0.89 [95 %CI 0.82-0.96]; κULDCT2 = 0.90 [0.81-0.98]; κULDCT3 = 0.91 [0.84-0.99]; κULDCT4 = 0.88 [0.78-0.97] on Qr49ADMIRE 4, and κULDCT1 = 0.88 [0.80-0.95]; κULDCT2 = 0.91 [0.86-0.96]; κULDCT3 = 0.87 [0.78-0.95]; and κULDCT4 = 0.88 [0.82-0.94] on Br49ADMIRE 3. LDCT classified as LungRADS 4B were correctly identified as LungRADS 4B at ULDCT3, with the lowest radiation exposure among the tested protocols (median effective doses were 0.31, 0.36, 0.27 and 0.37 mSv for ULDCT1, ULDCT2, ULDCT3, and ULDCT4, respectively).ULDCT by spectral shaping allows the detection and characterization of PNs with an excellent agreement with LDCT and can be proposed as a feasible approach in LCS.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
3秒前
柳贯一应助晴天吖采纳,获得10
4秒前
6秒前
8秒前
所所应助秋波采纳,获得10
9秒前
酷酷翅膀发布了新的文献求助10
10秒前
星辰大海应助大春采纳,获得10
11秒前
星辰大海应助youxianlang采纳,获得10
12秒前
12秒前
小蘑菇应助Violet采纳,获得10
13秒前
冷酷向薇完成签到,获得积分10
13秒前
森森完成签到,获得积分20
14秒前
liu发布了新的文献求助10
14秒前
万能图书馆应助forerunner采纳,获得20
15秒前
斯文败类应助科研通管家采纳,获得10
15秒前
NexusExplorer应助科研通管家采纳,获得10
15秒前
Lucas应助科研通管家采纳,获得10
16秒前
所所应助科研通管家采纳,获得10
16秒前
orixero应助科研通管家采纳,获得10
16秒前
Jasper应助科研通管家采纳,获得10
16秒前
宇宇完成签到 ,获得积分10
16秒前
天天快乐应助科研通管家采纳,获得10
16秒前
ding应助科研通管家采纳,获得10
17秒前
19秒前
20秒前
21秒前
yyy2025发布了新的文献求助10
21秒前
22秒前
24秒前
社会主义接班人完成签到 ,获得积分10
25秒前
yixuanshi完成签到,获得积分10
25秒前
跳跃惜筠发布了新的文献求助10
25秒前
不安愚志完成签到 ,获得积分10
26秒前
26秒前
唐Doctor发布了新的文献求助10
26秒前
youxianlang发布了新的文献求助10
26秒前
27秒前
27秒前
澤66发布了新的文献求助10
27秒前
liz完成签到 ,获得积分10
28秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
REAL-WORLD EFFICACY AND GENOMIC LANDSCAPE OF POLATUZUMA VEDOTIN-BASED FIRST-LINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A FOCUS ON TP53 MUTATIONS AND TREATMENT RESPONSE 500
Handbook of Luminescence Dating 500
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
Elgar Concise Encyclopedia of Space Law 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6944374
求助须知:如何正确求助?哪些是违规求助? 8629837
关于积分的说明 18305475
捐赠科研通 6379518
什么是DOI,文献DOI怎么找? 3079241
关于科研通互助平台的介绍 2120164
邀请新用户注册赠送积分活动 2056167